Patents by Inventor Anthonina Janssen

Anthonina Janssen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8431135
    Abstract: The present disclosure relates to proteins derived from OspC from bacteria of the genus Borrelia, in particular a protein which comprises a first OspC polypeptide, wherein the first OspC polypeptide is linked to a second OspC polypeptide via a disulphide bridge. The disclosure also relates to a method for the detection of antibodies against OspC and a method for the detection of a Borrelia infection, wherein a protein according to the disclosure is employed, and also to a diagnostic kit and a vaccine against Borrelia.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: April 30, 2013
    Assignee: Euroimmun Medizinische Labordiagnostika AG
    Inventors: Lars Komorowski, Christian Probst, Anthonina Janssen, Winfried Stöcker
  • Publication number: 20120177680
    Abstract: The present disclosure relates to proteins derived from OspC from bacteria of the genus Borrelia, in particular a protein which comprises a first OspC polypeptide, wherein the first OspC polypeptide is linked to a second OspC polypeptide via a disulphide bridge. The disclosure also relates to a method for the detection of antibodies against OspC and a method for the detection of a Borrelia infection, wherein a protein according to the disclosure is employed, and also to a diagnostic kit and a vaccine against Borrelia.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 12, 2012
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Lars Komorowski, Christian Probst, Anthonina Janssen, Winfried Stöcker
  • Patent number: 8163500
    Abstract: The present disclosure relates to proteins derived from OspC from bacteria of the genus Borrelia, in particular a protein which comprises a first OspC polypeptide, wherein the first OspC polypeptide is linked to a second OspC polypeptide via a disulphide bridge. The disclosure also relates to a method for the detection of antibodies against OspC and a method for the detection of a Borrelia infection, wherein a protein according to the disclosure is employed, and also to a diagnostic kit and a vaccine against Borrelia.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: April 24, 2012
    Assignee: Euroimmun Medizinische Labordiagnostika AG
    Inventors: Lars Komorowski, Christian Probst, Anthonina Janssen, Winfried Stöcker
  • Publication number: 20100150964
    Abstract: The present disclosure relates to proteins derived from OspC from bacteria of the genus Borrelia, in particular a protein which comprises a first OspC polypeptide, wherein the first OspC polypeptide is linked to a second OspC polypeptide via a disulphide bridge. The disclosure also relates to a method for the detection of antibodies against OspC and a method for the detection of a Borrelia infection, wherein a protein according to the disclosure is employed, and also to a diagnostic kit and a vaccine against Borrelia.
    Type: Application
    Filed: December 11, 2009
    Publication date: June 17, 2010
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Lars Komorowski, Christian Probst, Anthonina Janssen, Winfried Stöcker